ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,954.50
      1.59%
      US Tech 100
      20,332.80
      1.61%
      Dow Jones
      43,840.91
      1.39%
      Brent Oil
      73.045
      0.00%
      Bitcoin
      84,465.63
      0.13%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Essilorluxottica (EL) Quote

      Essilorluxottica

      Essilorluxottica (EL)

      Estee Lauder Companies Inc
      Engagement Labs Inc
      286.90
      -1.50
      (-0.52%)
      Closed March 01 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      286.90
      Bid
      284.60
      Ask
      287.00
      Volume
      1,423,291
      284.60 Day's Range 288.00
      188.25 52 Week Range 298.00
      Market Cap
      127.737B
      Previous Close
      288.40
      Open
      286.10
      Last Trade
      109
      @
      286.9
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      520,891
      Shares Outstanding
      445,231,933
      Dividend Yield
      1.38%
      PE Ratio
      55.35
      Earnings Per Share (EPS)
      5.3
      Revenue
      26.51B
      Net Profit
      2.36B

      About Essilorluxottica

      Sector
      Ophthalmic Goods
      Industry
      Ophthalmic Goods
      Website
      www.essilorluxottica.com
      Headquarters
      Charenton-le-pont, Val-de-marne, Fra
      Founded
      1971
      Essilorluxottica is listed in the Ophthalmic Goods sector of the Euronext with ticker EL. The last closing price for Essilorluxottica was 288.40 €. Over the last year, Essilorluxottica shares have traded in a share price range of 188.25 € to 298.00 €.

      Essilorluxottica currently has 445,231,933 shares outstanding. The market capitalization of Essilorluxottica is 128.40 € billion. Essilorluxottica has a price to earnings ratio (PE ratio) of 55.35.

      Ask ADVFN Intelligence (AI)

      EL Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-7-2.38176250425293.9294279655243285.64257169DE
      421.58.10097965335265.4298261623191282.52882397DE
      1257.625.1199302224229.3298226.5520891257.93798814DE
      2672.533.8152985075214.4298202.1506747236.36930921DE
      5290.5646.12407049196.34298188.25455408222.21897673DE
      156130.583.4398976982156.4298132.7474291183.69683672DE
      260164.65134.683026585122.2529886.76531695160.86528889DE

      EL - Frequently Asked Questions (FAQ)

      What is the current Essilorluxottica share price?
      The current share price of Essilorluxottica is 286.90 €
      How many Essilorluxottica shares are in issue?
      Essilorluxottica has 445,231,933 shares in issue
      What is the market cap of Essilorluxottica?
      The market capitalisation of Essilorluxottica is EUR 128.4B
      What is the 1 year trading range for Essilorluxottica share price?
      Essilorluxottica has traded in the range of 188.25 € to 298.00 € during the past year
      What is the PE ratio of Essilorluxottica?
      The price to earnings ratio of Essilorluxottica is 55.35
      What is the cash to sales ratio of Essilorluxottica?
      The cash to sales ratio of Essilorluxottica is 4.93
      What is the reporting currency for Essilorluxottica?
      Essilorluxottica reports financial results in EUR
      What is the latest annual turnover for Essilorluxottica?
      The latest annual turnover of Essilorluxottica is EUR 26.51B
      What is the latest annual profit for Essilorluxottica?
      The latest annual profit of Essilorluxottica is EUR 2.36B
      What is the registered address of Essilorluxottica?
      The registered address for Essilorluxottica is 147 RUE DE PARIS, CHARENTON-LE-PONT, VAL-DE-MARNE, 94220
      What is the Essilorluxottica website address?
      The website address for Essilorluxottica is www.essilorluxottica.com
      Which industry sector does Essilorluxottica operate in?
      Essilorluxottica operates in the OPHTHALMIC GOODS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALADOAdomos
      0.59 €
      (180.95%)
      		162.85k
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		24.87M
      DMSBSDiagnostic Medical Systems
      0.008 €
      (77.78%)
      		50k
      ALAMAAMA Corporation PLC
      0.233 €
      (29.81%)
      		847.73k
      LUDSLucibel DS
      0.0015 €
      (25.00%)
      		13.29k
      NEGDSNetmedia Group DS
      0.0001 €
      (-50.00%)
      		698
      ALPCVCerinnov Group
      0.618 €
      (-33.55%)
      		230.29k
      ALKALKALRAY SA
      0.641 €
      (-27.98%)
      		530.33k
      BPOSTBpost SA NV
      1.522 €
      (-26.83%)
      		6.5M
      FRVIAForvia SE
      8.442 €
      (-22.62%)
      		6.19M
      ATOAtos SE
      0.0032 €
      (0.00%)
      		472.41M
      BCPBanco Comercial Portugues SA
      0.5366 €
      (-4.89%)
      		135.45M
      BIOSBiosenic
      0.0029 €
      (-6.45%)
      		37.45M
      ALALOAcheterLouerFR
      0.0073 €
      (0.00%)
      		36.35M
      ALVERVergnet
      0.0004 €
      (0.00%)
      		33.19M

      Discussion

      View Full Feed
      02opida 02opida 31 seconds ago
      pick up time PHUN
      PHUN
      WALLnut WALLnut 2 minutes ago
      That's a loaded statement if you ask me. And better then some of Vivos tweets.


      RDGL
      RDGL
      Walter4 Walter4 2 minutes ago
      For shits and giggles compare these legitimate PRO's to Jake P Noch's dumpster fire of a scam.

      https://www.musicbusinessworldwide.com/ascaps-payouts-to-songwriters-and-publishers-rose-6-5-to-1-7bn-in-2024-as-membership-soared-past-1m-mark/
      SONG
      georgie18 georgie18 3 minutes ago
      Nope…boy…🥳
      HRTX
      02opida 02opida 4 minutes ago
      Let's see lots of News next week
      Zardiw Zardiw 5 minutes ago
      Not talking about a stock....lol......talking about smoking.......about an epiphany I had about it.........and that came from reading Carr's Easyway to stop smoking.....on Amazon..

      Z
      02opida 02opida 5 minutes ago
      GVTH
      02opida 02opida 5 minutes ago
      Saturday Morning Hi
      royal1 royal1 6 minutes ago
      Why sell at .0010 when you can sell at 1.00 and beyond?

      All you need is patience. LOL
      HMBL
      Zardiw Zardiw 6 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2012/2/9/qsezbOpinionDude.jpg

      Z
      SPZI
      HGilS HGilS 7 minutes ago
      Good stuff is coming
      ELTP
      justkate justkate 8 minutes ago
      JUST.......MUAHAHAHAHA!! ITS ALIVE!! ITS ALIVE!! ITS ALIVE!! MUAHAHAHAHA!! HEY, HAVE YA COUNTED THE BEARS OUTSIDE!! THEIR NOT EVEN TRYING TO HIDE!! AABBs WINTERS OVER AND IT'S JUST TO LATE SO WE SEND "DA BEARS" BACK TO HIBERNATE!! JUST CAN'T WAIT!! GLTA!!
      AABB
      ksquared ksquared 8 minutes ago
      Good ones, Mr. G. Thanks.
      Pyramid2 Pyramid2 11 minutes ago
      * * > > $TRNR < < * *

      https://elite.finviz.com/published_idea.ashx?t=TRNR&f=030125&i=TRNRi30084761395i

      What a great trade ClayTrader to bad " I " missed it!

      There is a lot of chatter on this come Monday about naked shorting coming from company Monday huge
      TRNR
      dukeb dukeb 12 minutes ago
      Yes. And in February you could have sold for .0010
      HMBL
      oldmystic oldmystic 12 minutes ago
      .things will be much more difficult than what most have been expecting!
      The case for 565: https://invst.ly/198zzj
      AVXL
      ergo sum ergo sum 12 minutes ago
      I think it’s more like this

      How Russian Money Helped Save Trump’s Business
      After his financial disasters two decades ago, no U.S. bank would touch him. Then foreign money began flowing in.
      https://foreignpolicy.com/2018/12/21/how-russian-money-helped-save-trumps-busines
      misterfishman misterfishman 13 minutes ago
      9 next week.
      IGPK
      WebSlinger WebSlinger 13 minutes ago
      Only one month left before chow time....

      LOL

      https://i.ibb.co/k2dJ7YWh/Old-Man-Eating-Silkworm-002.jpg
      KBLB
      DiscoverGold DiscoverGold 13 minutes ago
      Total Issues Traded Are Declining
      By: Tom McClellan | February 28, 2025

      www.mcoscillator.com/data/charts/weekly/tot_issues_ny_nq_feb2025.gif

      The total numbers of issues traded on both the NYSE and Nasdaq peaked with the stock market's peak at the end of 2021
      starman2 starman2 16 minutes ago
      https://www.entrepreneur.com/finance/tempus-ai-is-a-buy-if-you-can-handle-the-volatility/487637
      TEM
      Hoskuld Hoskuld 16 minutes ago
      K9UWA, Anavex's prioritizing filing an MAA with EMA over an NDA with the FDA looks increasingly smart. The dismantling of our institutional structures and emphasis of emotional identity over philosophical fidelity makes predicting US regulatory priorities and decision-making very difficult and risk
      AVXL
      oliven oliven 17 minutes ago
      Most posters confuse the share price that's obviously manipulated with the company's value,
      When Nasrat sells ELITE, many factors will be consider but not the s/p that's irrelevant in the negotiation.
      If the buyer is a foreign pharma in need of the American market, they'll pay a super
      ELTP
      JTORENCE JTORENCE 18 minutes ago
      DJPele Not me , This loser is now on "IGNORE"
      NWBO

      Your Recent History

      EU
      EL
      Essilorluxottica
      BIT
      EM1015
      ETF
      BIT
      S32519
      Societe Generale Effekten
      BIT
      P1RDW3
      BNP Paribas Issuance
      BOV
      BIVW39
      BlackRock Institutional ...
      BIT
      UC8HXL
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads